U.S. flag

An official website of the United States government

NM_030973.4(MED25):c.-12A>G AND Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome

Germline classification:
Benign (1 submission)
Last evaluated:
Oct 20, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001284886.10

Allele description [Variation Report for NM_030973.4(MED25):c.-12A>G]

NM_030973.4(MED25):c.-12A>G

Gene:
MED25:mediator complex subunit 25 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.33
Genomic location:
Preferred name:
NM_030973.4(MED25):c.-12A>G
HGVS:
  • NC_000019.10:g.49818330A>G
  • NG_017091.1:g.5052A>G
  • NM_001378355.1:c.-12A>G
  • NM_030973.4:c.-12A>GMANE SELECT
  • LRG_368t1:c.-12A>G
  • LRG_368:g.5052A>G
  • NC_000019.9:g.50321587A>G
  • NM_030973.3:c.-12A>G
Links:
dbSNP: rs114843375
NCBI 1000 Genomes Browser:
rs114843375
Molecular consequence:
  • NM_001378355.1:c.-12A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_030973.4:c.-12A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]

Condition(s)

Name:
Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome
Synonyms:
Basel-Vanagaite-Smirin-Yosef syndrome
Identifiers:
MONDO: MONDO:0014643; MedGen: C4225323; OMIM: 616449

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001470982ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process 2024)		Benign
(Oct 20, 2023) 		germlineclinical testing

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV001470982.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 28, 2024